Molecule to Market: Inside the outsourcing space
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars). Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
- Update frequency
- every 6 days
- Average duration
- 45 minutes
- Episodes
- 235
- Years Active
- 2020 - 2025
The entrepreneurial scientist
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Vice President of Life Sciences at Egnyte and the founder of the Bi…
The sales guru
In this episode of Molecule to Market, we do things a little differently with an experimental episode. You’ll go inside the outsourcing space of the global drug development sector with the best-selli…
Marathons. Wine. And 30 years in healthcare.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marco Chiado’ Piat, President, at Terumo Pharmaceutical Solutions part of Teru…
The industry guru
In this one hour special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Miller. If you’ve worked in the bio and pharmaceutical CD…
10 Trends for 2021
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with... Raman Sehgal, founder of ramarketing and the Molecule to Market podcast.
Yo…
The CDMO Disrupter
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tia Lyles-Williams, CEO of LucasPye Bio. Tia is the first African-American Que…
The biologic CDMO growth guy
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Roger Lias, Chief Executive Officer at Stelis Biopharma. A fellow-Brit, Roger …
Leading M&A at a top-5 global CDMO
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Quick, Executive Vice President, Corporate Development at Recipharm. In t…
The virotherapy virtuoso
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, C…
Roundtable: Collaboration and driving efficiency
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura C…
Roundtable: Latest trends in CDMO
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura C…
Roundtable: Clinical trials in 2020 and beyond
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura C…
Roundtable: Global geography and the pharma and bio supply chain
In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Ch…
Scientist & champion powerlifter
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shane Needham, Chief Founding Scientist, Director of the Board and Owner at Al…
From fax to SaaS: digitising the the pharma supply chain
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe, CEO at Veratrak. A graduate of Toronto and Oxford University, J…
Successful outsourcing partnerships: now and then
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian, Senior Vice President, Regulatory at Lyndra Therapeutics. To s…
Old world solutions won’t work for new world problems
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Lesina, Global Marketing Director of Pharma & Nutrition, Capsules and Hea…
Looking towards the future: A continuous mindset
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals. Like celebrated “one-club” fo…
Life in a boutique, specialist CDMO
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal, Business Development Director at IDIFARMA. A student of law and b…
Owning your authenticity
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award …